@FiercePharma: Our newest special report is live! The top 10 most expensive drugs of 2013. Feature | Follow @FiercePharma
@EricPFierce: Artes, InstrAction, Q-Biologicals team up on virus-like particle (VLP) platform for vet vax. FierceAnimalHealth story | Follow @EricPFierce
@CarlyHFierce: Pictures tell the story in AstraZeneca's breast cancer photo-sharing push. FiercePharmaMarketing story | Follow @CarlyHFierce
> Sanofi's ($SNY) investigational rotavirus vaccine has entered Phase III trials in India. Release
> Sucampo and Takeda have extended their licensing agreement for constipation drug Amitiza. Release
> In a Phase III trial, patients with moderate-to-servere Hidradenitis suppurativa who received AbbVie's ($ABBV) Humira, beginning at week 4, achieved a statistically significant greater response compared with those on placebo. Release
> The U.K.'s cost-effectiveness gatekeeper has released the draft of guidance on medicines optimization that it hopes will be more patient-centered. Report
> Cancer experts have issued a 12-point code aimed at preventing up to half of all new cases of the disease in Europe. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Steris to buy Synergy for $1.9B in another med tech tax inversion deal. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: PAD patients gain another treatment option as the FDA approves its first drug-coated balloon. Story | Follow @VarunSaxena2
@EmilyWFierce: The top 10 most expensive drugs of 2013 range from $100K to upwards of $500K. Find out which ones made the list here. FiercePharma feature | Follow @EmilyWFierce
@MichaelGFierce: With Roche's Herceptin, green tea component doubles drug accumulation in cancer cells. FierceDrugDelivery story | Follow @MichaelGFierce
> AstraZeneca's $2B cancer contender lines up for EU scrutiny. More
> Stanford engineers develop pressure sensor that could lead to advances in prosthetics, medicine. Story
> Eye care Dx maker RPS receives $28M in debt financing from OrbiMed. Article
Biotech News
@FierceBiotech: Novartis joins an Atlas syndicate to back cancer drug upstart Raze. News | Follow @FierceBiotech
@JohnCFierce: Pharma VCs cluster behind a brainchild of UK biotech pioneer Sir Greg Winter. Report | Follow @JohnCFierce
@DamianFierce: NPR talks CRISPR with Berkeley's Jennifer Doudna, who happens to be a founder of Fierce 15 winner. More | Follow @DamianFierce
@EmilyMFierce: These 10 drugs could stop Ebola. Feature | Follow @EmilyMFierce
> Astellas dives into gene therapy with a Harvard expert in tow. Story
> AstraZeneca's $2B cancer contender lines up for EU scrutiny. More
> GW Pharma's cannabis-based drug comes up short in ulcerative colitis. Article
Biotech Research News
> Out-of-control neural stem cell growth may play part in autism. News
> HIV spikes reveal clues for vaccine development. Report
> Amicus drug improves Parkinson's symptoms in mice. Story
> Beta cells produced from stem cells could treat Type 1 diabetes. More
> Tetraphase antibiotic candidate kills gram-negative, resistant bacteria. Article
Pharma Manufacturing News
> Indian drugmakers scramble to prevent shortages of HIV/AIDS meds. Item
> FDA chastises Sun for weak follow-through on drug recalls. News
> Sources: Ranbaxy's key U.S. operations losing top dogs. More
> Mapp, HHS scrambling to find ways to supercharge production of Ebola drug. Story
> GSK adds jobs at North Carolina plant, expecting new drugs to take off. Article
And Finally... Janssen's Sirturo has won the UK Prix Galien Award for most innovative orphan drug.